301201 诚达药业
午间休市 06-29 11:30:00
资讯
新帖
简况
诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%
证券之星 · 06-26 17:56
诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%
6月25日诚达药业发布公告，股东减持698.75万股
证券之星 · 06-25
6月25日诚达药业发布公告，股东减持698.75万股
股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元
证券之星 · 06-22
股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元
每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易
证券之星 · 06-21
每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易
股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元
证券之星 · 06-18
股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元
6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股
证券之星 · 06-16
6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股
股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元
证券之星 · 06-16
股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元
诚达药业：中邮证券投资者于6月10日调研我司
证券之星 · 06-10
诚达药业：中邮证券投资者于6月10日调研我司
诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司
证券之星 · 06-09
诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司
6月4日诚达药业发布公告，股东减持38.12万股
证券之星 · 06-04
6月4日诚达药业发布公告，股东减持38.12万股
股市必读：诚达药业（301201）6月2日披露最新机构调研信息
证券之星 · 06-03
股市必读：诚达药业（301201）6月2日披露最新机构调研信息
诚达药业：申万宏源投资者于6月2日调研我司
证券之星 · 06-02
诚达药业：申万宏源投资者于6月2日调研我司
股市必读：诚达药业（301201）5月22日董秘有最新回复
证券之星 · 05-25
股市必读：诚达药业（301201）5月22日董秘有最新回复
诚达药业：小核酸药物中间体为重要拓展方向
证券之星 · 05-22
诚达药业：小核酸药物中间体为重要拓展方向
5月21日诚达药业跌5.91%，富国睿泽回报混合基金重仓该股
证券之星 · 05-21
5月21日诚达药业跌5.91%，富国睿泽回报混合基金重仓该股
诚达药业（301201）披露2025年年度跟踪报告，5月18日股价下跌0.67%
证券之星 · 05-18
诚达药业（301201）披露2025年年度跟踪报告，5月18日股价下跌0.67%
诚达药业（301201）披露2025年度业绩说明会公告，5月14日股价下跌2.28%
证券之星 · 05-14
诚达药业（301201）披露2025年度业绩说明会公告，5月14日股价下跌2.28%
诚达药业最新公告：前海晟泰拟减持不超4.89%股份
证券之星 · 05-11
诚达药业最新公告：前海晟泰拟减持不超4.89%股份
诚达药业：公司积极推广生物催化、连续流微反应等绿色前沿技术应用
证券之星 · 05-08
诚达药业：公司积极推广生物催化、连续流微反应等绿色前沿技术应用
每周股票复盘：诚达药业（301201）Q1净利增600.15%
证券之星 · 05-03
每周股票复盘：诚达药业（301201）Q1净利增600.15%
加载更多
公司概况
公司名称：
诚达药业股份有限公司
所属行业：
医药制造业
上市日期：
2022-01-20
主营业务：
诚达药业股份有限公司的主营业务是为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO研发生产服务，左旋肉碱系列产品、原料药的研发、生产和销售以及干细胞药物的研发。公司的主要产品是定制类产品和服务、自主销售类产品、贸易类、其他业务。
发行价格：
72.69
{"stockData":{"symbol":"301201","market":"SZ","secType":"STK","nameCN":"诚达药业","latestPrice":37.33,"timestamp":1782707901000,"preClose":36.17,"halted":0,"volume":6221740,"delay":0,"changeRate":0.0321,"floatShares":109000000,"shares":155000000,"eps":-0.0228,"marketStatus":"午间休市","change":1.16,"latestTime":"06-29 11:30:00","open":36.05,"high":37.79,"low":35.13,"amount":228000000,"amplitude":0.0735,"askPrice":37.33,"askSize":4,"bidPrice":37.32,"bidSize":36,"shortable":0,"etf":0,"ttmEps":-0.0228,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782709200000},"marketStatusCode":3,"adr":0,"adjPreClose":36.17,"symbolType":"stock","openAndCloseTimeList":[[1782696600000,1782703800000],[1782709200000,1782716400000]],"highLimit":39.79,"lowLimit":32.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":154713824,"isCdr":false,"pbRate":2.66,"roa":"--","roe":"0.33%","epsLYR":-0.0787,"committee":0.104762,"marketValue":5775000000,"turnoverRate":0.0573,"status":0,"floatMarketCap":4052000000},"requestUrl":"/m/hq/s/301201/","defaultTab":"news","newsList":[{"id":"2646355402","title":"诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646355402","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646355402?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:56","pubTimestamp":1782467802,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，诚达药业报收于36.17元，较前一交易日下跌3.52%，最新总市值为55.96亿元。诚达药业股份有限公司于2026年6月25日发布公告，原持股5%以上股东深圳前海晟泰投资企业在2026年6月3日至6月24日期间，通过集中竞价和大宗交易方式累计减持公司股份7,368,706股，占公司总股本比例4.76%。其中集中竞价减持381,206股，大宗交易减持6,987,500股。本次减持后，前海晟泰持有股份降至748,091股，占总股本比例0.48%，不再为持股5%以上股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646706538","title":"6月25日诚达药业发布公告，股东减持698.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646706538","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646706538?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:01","pubTimestamp":1782388902,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日诚达药业发布公告《诚达药业:关于原持股5%以上股东减持计划实施结果的公告》，其股东深圳前海晟泰投资企业(有限合伙)于2026年6月11日至2026年6月22日间合计减持698.75万股，占公司目前总股本的4.5164%，变动期间该股股价上涨5.9%，截止6月22日收盘报35.7元。股东增减持详情见下表：根据诚达药业2026年一季报公布的十大股东详情如下：本文数据来源于诚达药业公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500039689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645016355","title":"股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645016355","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645016355?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:10","pubTimestamp":1782072621,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，诚达药业报收于35.72元，上涨0.85%，换手率3.81%，成交量4.13万手，成交额1.47亿元。交易信息汇总资金流向6月18日主力资金净流出376.8万元，占总成交额0.0%；游资资金净流出94.34万元，占总成交额0.0%；散户资金净流入471.15万元，占总成交额0.0%。大宗交易6月18日诚达药业发生2笔折价18%的大宗交易，合计成交4024.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096618","title":"每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645096618?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:00","pubTimestamp":1781982032,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，诚达药业报收于35.72元，较上周的33.18元上涨7.66%。本周，诚达药业6月16日盘中最高价报36.31元。诚达药业当前最新总市值55.26亿元，在医疗服务板块市值排名29/51，在两市A股市值排名3049/5206。本周关注点交易信息汇总：6月15日至18日，诚达药业连续出现多笔折价约18%的大宗交易，合计成交金额超1.19亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644255757","title":"股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644255757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644255757?lang=zh_cn&edition=full","pubTime":"2026-06-18 02:27","pubTimestamp":1781720831,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，诚达药业报收于35.42元，上涨0.83%，换手率4.24%，成交量4.6万手，成交额1.63亿元。当日关注点交易信息汇总：6月17日主力资金净流入1041.39万元，游资资金净流入152.28万元，散户资金净流出1193.67万元； 交易信息汇总：当日发生2笔折价18.13%的大宗交易，合计成交3190万元。大宗交易6月17日诚达药业发生2笔大宗交易，折价率18.13%，合计成交金额3190万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643737090","title":"6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643737090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643737090?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:43","pubTimestamp":1781599416,"startTime":"0","endTime":"0","summary":"证券之星消息，6月16日诚达药业涨5.75%，收盘报35.13元，换手率5.88%，成交量6.38万手，成交额2.21亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600029140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643214200","title":"股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643214200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643214200?lang=zh_cn&edition=full","pubTime":"2026-06-16 01:55","pubTimestamp":1781546112,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，诚达药业报收于33.22元，上涨0.12%，换手率3.4%，成交量3.69万手，成交额1.22亿元。当日关注点交易信息汇总：6月15日诚达药业主力资金净流出810.08万元，游资与散户资金分别净流入222.07万元、588.02万元。大宗交易6月15日诚达药业现1笔折价18%的大宗交易，合计成交2097.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600001376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642425630","title":"诚达药业：中邮证券投资者于6月10日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2642425630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642425630?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:02","pubTimestamp":1781092939,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月10日诚达药业发布公告称中邮证券分析师 盛丽华 陈灿 辛家齐于2026年6月10日调研我司。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000038073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642641724","title":"诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2642641724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642641724?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:01","pubTimestamp":1781002915,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月9日诚达药业发布公告称兴业证券分析师 乔波耀、招商证券分析师 侯彪、中泰证券分析师 杨涛于2026年6月9日调研我司。公司将积极推动干细胞项目国内IND申报及临床研究，加快产品上市进程。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900032719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","301201","601377","06099","BK0012","BK0188","BK0010","BK0239","BK0276","600999","BK1564","BK1147","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815483","title":"6月4日诚达药业发布公告，股东减持38.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815483?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:01","pubTimestamp":1780570866,"startTime":"0","endTime":"0","summary":"证券之星消息，6月4日诚达药业发布公告《诚达药业:诚达药业股份有限公司简式权益变动报告书》，其股东深圳前海晟泰投资企业(有限合伙)于2026年6月3日合计减持38.12万股，占公司目前总股本的0.2464%，变动期间该股股价上涨3.75%，截止6月3日收盘报34.86元。股东增减持详情见下表：根据诚达药业2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400035383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640928527","title":"股市必读：诚达药业（301201）6月2日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2640928527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640928527?lang=zh_cn&edition=full","pubTime":"2026-06-03 03:02","pubTimestamp":1780426939,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，诚达药业报收于33.6元，上涨0.87%，换手率4.46%，成交量4.84万手，成交额1.59亿元。来自机构调研要点：公司左旋肉碱系列产品2025年实现营收1.63亿元，同比增长13.94%，呈现量价齐升态势。交易信息汇总资金流向6月2日主力资金净流入355.32万元；游资资金净流入766.9万元；散户资金净流出1122.22万元。小分子GLP-1药物中间体已进入商业化供货阶段，公司具备相应生产能力，能够满足下游客户的采购需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300002830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640946748","title":"诚达药业：申万宏源投资者于6月2日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2640946748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640946748?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:02","pubTimestamp":1780408923,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月2日诚达药业发布公告称申万宏源张静含 余玉君于2026年6月2日调研我司。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200046750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","BK0239","000166","BK0183","BK1147","BK0028","06806","BK1564","BK0276","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638301079","title":"股市必读：诚达药业（301201）5月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2638301079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638301079?lang=zh_cn&edition=full","pubTime":"2026-05-25 01:36","pubTimestamp":1779644173,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，诚达药业报收于35.45元，下跌2.74%，换手率5.67%，成交量6.15万手，成交额2.19亿元。董秘最新回复投资者： 1.请问诚达药业在下面项目中参与相关产品中间体、原料药的合作和生产吗？因客户信息及合作情况涉及商业秘密，为保护合作双方合法权益，公司不便公开，敬请谅解。当日关注点来自交易信息汇总：5月22日主力资金净流出2105.9万元，散户资金净流入3236.64万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637513394","title":"诚达药业：小核酸药物中间体为重要拓展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2637513394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637513394?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:12","pubTimestamp":1779437531,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：1.请问诚达药业在下面项目中参与相关产品中间体、原料药的合作和生产吗？以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200028607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637538687","title":"5月21日诚达药业跌5.91%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637538687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637538687?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:52","pubTimestamp":1779353557,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日诚达药业跌5.91%创60日新低，收盘报36.45元，换手率6.56%，成交量7.12万手，成交额2.69亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。该公募基金现任基金经理为张啸伟。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100031007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636602438","title":"诚达药业（301201）披露2025年年度跟踪报告，5月18日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636602438","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636602438?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:58","pubTimestamp":1779098297,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，诚达药业报收于38.71元，较前一交易日下跌0.67%，最新总市值为59.89亿元。该股当日开盘39.16元，最高39.26元，最低38.25元，成交额达1.84亿元，换手率为4.39%。公司于近日披露《光大证券股份有限公司关于诚达药业股份有限公司2025年年度跟踪报告》。保荐机构共查询募集资金专户12次，现场检查1次，发表专项意见5次，开展培训1次。公司及股东承诺均正常履行，无违规情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800028418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635871348","title":"诚达药业（301201）披露2025年度业绩说明会公告，5月14日股价下跌2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635871348","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635871348?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:08","pubTimestamp":1778753298,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，诚达药业报收于40.23元，较前一交易日下跌2.28%，最新总市值为62.24亿元。该股当日开盘41.16元，最高41.6元，最低40.12元，成交额达2.05亿元，换手率为4.62%。诚达药业于2026年5月14日发布《关于举办2025年度业绩说明会的公告》。公告显示，公司将于2026年5月15日15:00-17:00通过网络互动方式在价值在线举办2025年度业绩说明会，介绍公司经营业绩、发展战略等情况。说明会结束后可通过价值在线或易董app查看会议情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400034356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283455","title":"诚达药业最新公告：前海晟泰拟减持不超4.89%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634283455?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:09","pubTimestamp":1778497760,"startTime":"0","endTime":"0","summary":"诚达药业(301201.SZ)公告称，持股5.36%的股东深圳前海晟泰投资企业（有限合伙）（简称“前海晟泰”）计划以集中竞价或大宗交易方式减持公司股份不超过740万股(占公司剔除回购专户股份数后总股本比例4.89%)。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100029533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633101164","title":"诚达药业：公司积极推广生物催化、连续流微反应等绿色前沿技术应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2633101164","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633101164?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:48","pubTimestamp":1778201298,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：3.氮杂环丁烷小环结构是抗癌、神经、抗病毒创新药的核心骨架，请问贵公司在该类高难度小环中间体领域，是否有布局连续流加氢、电催化等绿色工艺？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800007656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632729156","title":"每周股票复盘：诚达药业（301201）Q1净利增600.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632729156","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632729156?lang=zh_cn&edition=full","pubTime":"2026-05-03 04:28","pubTimestamp":1777753690,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，诚达药业报收于41.24元，较上周的40.25元上涨2.46%。本周，诚达药业4月28日盘中最高价报42.95元。诚达药业当前最新总市值63.8亿元，在医疗服务板块市值排名30/51，在两市A股市值排名2894/5200。本周关注点业绩披露要点：诚达药业2026年一季报显示，归母净利润700.2万元，同比上升600.15%。股本股东变化股东户数变动截至2026年3月31日，诚达药业股东户数为1.43万户，较2025年12月31日增加1333.0户，增幅10.28%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782707951120,"stockEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0.08},{"period":"3month","weight":-0.2195},{"period":"6month","weight":-0.1378},{"period":"1year","weight":0.7564},{"period":"ytd","weight":-0.1113}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诚达药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14295人(较上一季度增加10.28%)","perCapita":"7593股","listingDate":"2022-01-20","address":"浙江省嘉兴市嘉善县惠民街道黄河路36号","registeredCapital":"15471万元","survey":" 诚达药业股份有限公司的主营业务是为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO研发生产服务，左旋肉碱系列产品、原料药的研发、生产和销售以及干细胞药物的研发。公司的主要产品是定制类产品和服务、自主销售类产品、贸易类、其他业务。","listedPrice":72.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诚达药业,301201,诚达药业股票,诚达药业股票老虎,诚达药业股票老虎国际,诚达药业行情,诚达药业股票行情,诚达药业股价,诚达药业股市,诚达药业股票价格,诚达药业股票交易,诚达药业股票购买,诚达药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}